as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹749.6
Change
+8.7 (1.17%)
Open
₹740.0
Prev. Close
₹740.9
Day High
₹753.35
Day Low
₹734.0
Volume Analysis
Traded
75,418
Delivered
30,441
Delivery %
40.36%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (2)
- •Strong return on equity (23.2%)
- •Strong operating margin (20.0%)
Weaknesses (1)
- •Trading within 3% of its 52-week low (₹734.0)
Opportunities (2)
- •Strong 3-year EPS growth (25.8%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹776.65 | ₹765.0 | ₹757.3 | ₹745.65 | ₹737.95 | ₹726.3 | ₹718.6 |
| Fibonacci | ₹765.0 | ₹757.61 | ₹753.04 | ₹745.65 | ₹738.26 | ₹733.69 | ₹726.3 |
| Camarilla | ₹754.92 | ₹753.15 | ₹751.37 | ₹745.65 | ₹747.83 | ₹746.05 | ₹744.28 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-13.73%
1 Week
+0.52%
1 Month
-4.36%
3 Months
-14.76%
6 Months
-15.74%
1 Year
-9.3%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹768.72
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
19.79%
Net margin 11.69% × asset turnover 0.92x × equity multiplier 1.84x
Company Overview
Sector
Chemicals
Market Cap
₹6,763 Cr
P/E (TTM)
10.8
ROE
23.2%
Book Value
₹348.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Sharda Cropchem Ltd. holds up reasonably well on TopFund's composite fundamentals check within the Chemicals sector, at 66/100. The strongest factor is Financial Strength (100/100), while Momentum (3/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (23.2%); strong operating margin (20.0%); trading within 3% of its 52-week low (₹734.0). Strong 3-year EPS growth (25.8%).
TopFund Score — Fundamentals Quality
66/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has delivered good profit growth of 23.8% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 43.8%
- −Company has a low return on equity of 13.2% over last 3 years.
- −Company has high debtors of 166 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Advertisement in relation to transfer of dividend and equity shares of the company to IEPF Authority.
Earnings Call Transcript of the conference call held on 30th July, 2026
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 638 | 581 | 632 | 1,312 | 785 | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 |
| Expenses + | 697 | 560 | 563 | 1,057 | 708 | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 |
| Operating Profit | -59 | 21 | 69 | 255 | 77 | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 |
| OPM % | -9.0% | 3.6% | 11.0% | 19.0% | 10.0% | 12.0% | 12.0% | 17.0% | 22.0% | 14.0% | 19.0% | 24.0% | 17.0% |
| Other Income + | 26 | 24 | 12 | -2 | 19 | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 |
| Interest | 1 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| Depreciation | 70 | 74 | 69 | 54 | 65 | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 |
| Profit before tax | -105 | -34 | 12 | 198 | 31 | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 |
| Tax % | -15.0% | -18.0% | 62.0% | 28.0% | 11.0% | 7.0% | 32.0% | 20.0% | 16.0% | 13.0% | 19.0% | 24.0% | 26.0% |
| Net Profit + | -89 | -28 | 5 | 143 | 27 | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 |
| EPS in Rs | -10 | -3 | 1 | 16 | 3 | 5 | 3 | 23 | 16 | 8 | 16 | 35 | 10 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,061 | 1,222 | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | 3,580 | 4,045 | 3,163 | 4,320 | 5,268 | 5,357 |
| Expenses + | 878 | 941 | 1,075 | 1,343 | 1,621 | 1,653 | 1,945 | 2,884 | 3,386 | 2,860 | 3,705 | 4,209 | 4,310 |
| Operating Profit | 183 | 281 | 324 | 364 | 376 | 350 | 450 | 696 | 659 | 303 | 615 | 1,059 | 1,047 |
| OPM % | 17.0% | 23.0% | 23.0% | 21.0% | 19.0% | 17.0% | 19.0% | 19.0% | 16.0% | 10.0% | 14.0% | 20.0% | 20.0% |
| Other Income + | 25 | 23 | 14 | 9 | -22 | -12 | 46 | 29 | 40 | 60 | 60 | 142 | 108 |
| Interest | 9 | 8 | 9 | 15 | 20 | 16 | 16 | 15 | 20 | 24 | 21 | 21 | 3 |
| Depreciation | 23 | 35 | 56 | 70 | 99 | 137 | 170 | 245 | 248 | 267 | 275 | 325 | 347 |
| Profit before tax | 175 | 261 | 272 | 287 | 235 | 185 | 309 | 464 | 431 | 72 | 378 | 856 | 805 |
| Tax % | 30.0% | 33.0% | 30.0% | 34.0% | 25.0% | 11.0% | 26.0% | 25.0% | 21.0% | 56.0% | 20.0% | 20.0% | — |
| Net Profit + | 123 | 175 | 190 | 191 | 176 | 165 | 229 | 349 | 342 | 32 | 304 | 681 | 626 |
| EPS in Rs | 14 | 19 | 21 | 21 | 20 | 18 | 25 | 39 | 38 | 4 | 34 | 75 | 69 |
| Dividend Payout % | 18.0% | 21.0% | 19.0% | 19.0% | 20.0% | 22.0% | 20.0% | 16.0% | 16.0% | 85.0% | 27.0% | 20.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 564 | 715 | 870 | 1,045 | 1,194 | 1,313 | 1,524 | 1,822 | 2,142 | 2,147 | 2,410 | 3,046 |
| Borrowings + | 38 | 2 | 0 | 170 | 0 | 0 | 81 | 47 | 3 | 18 | 8 | 0 |
| Other Liabilities + | 354 | 522 | 686 | 914 | 914 | 940 | 1,163 | 1,779 | 2,108 | 1,773 | 2,205 | 2,620 |
| Total Liabilities | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Fixed Assets + | 88 | 130 | 210 | 226 | 372 | 416 | 544 | 592 | 668 | 708 | 750 | 989 |
| CWIP | 149 | 210 | 232 | 360 | 220 | 161 | 131 | 212 | 204 | 283 | 291 | 247 |
| Investments | 95 | 90 | 61 | 22 | 212 | 116 | 83 | 134 | 32 | 159 | 294 | 361 |
| Other Assets + | 715 | 899 | 1,143 | 1,611 | 1,394 | 1,650 | 2,099 | 2,800 | 3,439 | 2,878 | 3,377 | 4,159 |
| Total Assets | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Equity Capital | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 46 | 197 | 181 | 17 | 556 | 146 | 246 | 267 | 328 | 341 | 604 | 656 |
| Cash from Investing Activity + | -19 | -113 | -104 | -160 | -351 | -59 | -282 | -205 | -112 | -393 | -496 | -445 |
| Cash from Financing Activity + | -24 | -89 | -38 | 132 | -215 | -60 | 43 | -91 | -97 | -37 | -68 | -118 |
| Net Cash Flow | 3 | -6 | 40 | -11 | -11 | 27 | 8 | -29 | 120 | -89 | 40 | 93 |
| CFO/OP | 58 | 95 | 73 | 27 | 169 | 60 | 68 | 49 | 60 | 129 | 103 | 68 |
| Free Cash Flow | -34 | 196 | 39 | -185 | 413 | -30 | 15 | 33 | 84 | 69 | 211 | 158 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 10.87% | 10.7% | 10.63% | 10.29% | 9.91% | 11.33% | 10.21% | 10.33% | 10.65% | 11.02% | 10.88% | 12.88% |
| Promoters | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% | 74.82% |
| FII | 2.01% | 2.06% | 2.14% | 2.02% | 2.52% | 3.77% | 4.69% | 5.48% | 5.26% | 4.2% | 4.6% | 3.12% |
| DII | 12.29% | 12.42% | 12.41% | 12.87% | 12.77% | 10.07% | 10.28% | 9.38% | 9.26% | 9.95% | 9.7% | 9.18% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Sharda Cropchem Ltd. (this stock) | 6,763 | 10.8 | 2.16 | 23.2% |
| Fineotex Chemical Limited | 6,591 | 53.9 | 7.47 | 13.5% |
| Neogen Chemicals Limited | 7,166 | 202.0 | 7.72 | 3.58% |
| Balaji Amines Limited | 7,180 | 35.2 | 3.63 | 8.74% |
| Guj State Fert & Chem Ltd | 6,180 | 8.94 | 0.5 | 5.51% |
| Rain Industries Limited | 7,378 | 13.7 | 0.92 | 0.6% |
| Archean Chemical Ind Ltd | 6,030 | 62.3 | 3.11 | 5.42% |
Which Mutual Funds Hold Sharda Cropchem Ltd.?
Frequently Asked Questions about Sharda Cropchem Ltd.
Sharda Cropchem Ltd. (SHARDACROP) closed at ₹749.6 on NSE on 25 September 2026, up 8.7 (1.17%) from the previous close.
Sharda Cropchem Ltd. trades on the NSE (National Stock Exchange of India) under the symbol SHARDACROP.
Sharda Cropchem Ltd. has a trailing twelve-month P/E (price-to-earnings) ratio of 10.8.
Sharda Cropchem Ltd. has a dividend yield of 2.0%.
Sharda Cropchem Ltd.'s 52-week high is ₹1,298.0 and its 52-week low is ₹734.0.
Sharda Cropchem Ltd. has a market capitalisation of ₹6,763 crore.
Sharda Cropchem Ltd. has a TopFund Quality Score of 66/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Sharda Cropchem Ltd.?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.